Effects of Obesity and Weight Loss in Patients With Nononcological Urological Disease

Journal of Urology

Volumn 181, Issue 6, 2009, Pages 2424-2429

  Natarajan, Vivek ^a   Master, Viraj ^a   Ogan, Kenneth ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bariatric surgery; physiological; prostatic hyperplasia; sexual dysfunction; urinary incontinence; urolithiasis

Indexed keywords

SIBUTRAMINE;

DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; FOOD INTAKE; HUMAN; MICTURITION DISORDER; OBESITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; RISK REDUCTION; SEXUAL FUNCTION; URINARY TRACT DISEASE; URINE INCONTINENCE; UROLITHIASIS; WEIGHT REDUCTION;

FEMALE; HUMANS; MALE; OBESITY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; URINARY CALCULI; URINATION DISORDERS; UROLOGIC DISEASES; WEIGHT LOSS;

EID: 67349146802     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.01.107     Document Type: Review

References (41)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series, 894 (2007), World Health Organization, Geneva i-xii
2. CDC. Behavioral Risk Factor Surveillance System. www.cdc.gov/brfss Accessed January 19, 2009
3. Mydlo J.H. The impact of obesity in urology. Urol Clin North Am 31 (2004) 275
4. Bouldin M.J., Ross L.A., Sumrall C.D., Loustalot F.V., Low A.K., and Land K.K. The effect of obesity surgery on obesity comorbidity. Am J Med Sci 331 (2006) 183
5. Taylor E.N., and Curhan G.C. Body size and 24-hour urine composition. Am J Kidney Dis 48 (2006) 905
6. Taylor E.N., Stampfer M.J., and Curhan G.C. Obesity, weight gain, and the risk of kidney stones. JAMA 293 (2005) 455
7. Siener R., Glatz S., Nicolay C., and Hesse A. The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12 (2004) 106
8. Powell C.R., Stoller M.L., Schwartz B.F., Kane C., Gentle D.L., Bruce J.E., et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology 55 (2000) 825
9. Yun S.J., Ha Y.-S., Kim T.H., Kim Y.-J., Lee S.-C., and Kim W.J. Obesity and phosphaturia as the important predictors for recurrence in first-time urinary stone formers. J Urol 177 suppl (2007) 452 abstract 1369
10. Ekeruo W.O., Tan Y.H., Young M.D., Dahm P., Maloney M.E., Mathias B.J., et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 172 (2004) 159
11. American Society for Metabolic and Bariatric Surgery. www.asbs.org Accessed January 19, 2009
12. Palomar R., Fernandez-Fresnedo G., Dominguez-Diez A., Lopez-Deogracias M., Olmedo F., Martin de Francisco A.L., et al. Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile. Obes Surg 15 (2005) 794
13. Pedro R.N., Duffey B., Weiland D., Melquist J., Kriedberg C., Ikramuddin S., et al. Impact of bariatric surgery on urinary stone risk factors in the morbidly obese. J Urol 177 suppl (2007) 451 abstract 1367
14. Asplin J.R., and Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 177 (2007) 565
15. Sinha M.K., Collazo-Clavell M.L., Rule A., Milliner D.S., Nelson W., Sarr M.G., et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 72 (2007) 100
16. Leitao V.A., Mutafyan G., Haleblian G.E., Robinson M.R., Pierre S.A., Pryor A., et al. Correlation between stone formation and weight loss after Roux-en-Y gastric bypass. J Urol 177 suppl (2007) 450 abstract 1366
17. Larsen S.H., Wagner G., and Heitmann B.L. Sexual function and obesity. Int J Obes 31 (2007) 1189
18. Muller A., and Mulhall J.P. Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol 16 (2006) 435
19. Bacon C.G., Mittleman M.A., Kawachi I., Giovannucci E., Glasser D.B., and Rimm E.B. A prospective study of risk factors for erectile dysfunction. J Urol 176 (2006) 217
20. Corona G., Mannucci E., Schulman C., Petrone L., Mansani R., Cilotti A., et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 50 (2006) 595
21. Boyanov M.A., Boneva Z., and Christov V.G. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 6 (2003) 1
22. Liu P.Y., Wishart S.M., Celermajer D.S., Jimenez M., Pierro I.D., Conway A.J., et al. Do reproductive hormones modify insulin sensitivity and metabolism in older men?. A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. Eur J Endocrinol 148 (2003) 55
23. Chen R.Y.T., Wittert G.A., and Andrews G.R. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab 8 (2006) 429
24. Kolotkin R.L., Binks M., Crosby R.D., Ostbye T., Gress R.E., and Adams T.D. Obesity and sexual quality of life. Obesity 14 (2006) 472
25. Esposito K., Giugliano F., Di Palo C., Giugliano G., Marfella R., D'Andrea F., et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291 (2004) 2978
26. Derby C.A., Mohr B.A., Goldstein I., Feldman H.A., Johannes C.B., and McKinlay J.B. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?. Urology 56 (2000) 302
27. Kinzl J.F., Trefalt E., Fiala M., Hotter A., Biebl W., and Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg 11 (2001) 455
28. Kim K.K., Kang H.C., Kim S.S., and Youn B.B. Influence of weight reduction by sibutramine on female sexual function. Int J Obes 30 (2006) 758
29. Lee S., Min H.G., Choi S.H., Kim Y.J., Oh S.W., Kim Y.J., et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity 14 (2006) 172
30. Parsons J.K., Carter H.B., Partin A.W., Windham B.G., Metter E.J., Ferrucci L., et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 91 (2006) 2562
31. Xie L.-P., Bai Y., Zhang X.-Z., Zheng X.-Y., Yao K.-S., Xu L., et al. Obesity and benign prostatic enlargement: a large observational study in China. Urology 69 (2007) 680
32. Tikkinen K.A., Auvinen A., Huhtala H., and Tammela T.L.J. Nocturia and obesity: a population-based study in Finland. Am J Epidemiol 163 (2006) 1003
33. Sugerman H., Windsor A., Bessos M., and Wolfe L. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Int Med 241 (1997) 71
34. McGrother C.W., Donaldson M.M.K., Hayward T., Matthews R., Dallosso H.M., Hyde C., et al. Urinary storage symptoms and comorbidities: a prospective population cohort study in middle-aged and older women. Age Ageing 35 (2006) 16
35. Subak L.L., Whitcomb E., Shen H., Saxton J., Vittinghoff E., and Brown J.S. Weight loss: a novel and effective treatment for urinary incontinence. J Urol 174 (2005) 190
36. Sugerman H.J. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 81 (2001) 1063
37. Bump R.C., Sugerman H.J., Fantl J.A., and McClish D.K. Obesity and lower urinary tract function in women: effect of surgically induced weight loss. Am J Obstet Gynecol 167 (1992) 392
38. Kristal A.R., Arnold K.B., Schenk J.M., Neuhouser M.L., Weiss N., Goodman P., et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177 (2007) 1395
39. U.S. Department of Health and Human Service USDoA. Dietary Guidelines for Americans. 6th ed. (2005), Government Printing Office, Washington, D. C
40. Carels R.A., Young K.M., Coit C., Clayton A.M., Spencer A., and Hobbs M. Can following the caloric restriction recommendations from the Dietary Guidelines for Americans help individuals lose weight?. Eat Behav 9 (2008) 328
41. Hollis J.F., Gullion C.M., Stevens V.J., Brantley P.J., Appel L.J., Ard J.D., et al. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med 35 (2008) 118